Zevra Therapeutics, Inc. (ZVRA) Misses Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts ZVRA Hot Sheet
Join SI Premium – FREE
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) reported Q1 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Zevra Therapeutics, Inc. (ZVRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
- Snowflake (SNOW) Tops Q2 EPS by 17c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
